A NOVEL TIE2 AGAINST IV MEDICATION FOR THE TREATMENT OF ALI/ARDS IN MILITARY CASUALTIES AND CIVILIANS

$2,781,527FY2020Defense Health AgencyDOD

Vasomune Therapeutics Inc

Investigators